Company ANGLE plc

Equities

AGL

GB0034330679

Advanced Medical Equipment & Technology

Market Closed - London S.E. 11:35:28 2024-07-12 am EDT 5-day change 1st Jan Change
15.25 GBX +0.99% Intraday chart for ANGLE plc +3.39% +29.79%

Business Summary

ANGLE plc is a United Kingdom-based liquid biopsy company with circulating tumor cell (CTC) solutions for use in research, drug development and clinical oncology using a simple blood sample. Its circulating tumor cell (CTC) harvesting technology known as the Parsortix PC1 System enables complete downstream analysis of the sample, including whole cell imaging and proteomic analysis and full genomic and transcriptomic molecular analysis. The Parsortix PC1 system is a medical device for the capture and harvest of intact CTCs from metastatic breast cancer (MBC) patient blood for user-validated analysis. Its commercial businesses focus on diagnostic products and clinical services. Its diagnostic products include the Parsortix system and associated consumables. Its services include custom made assay development and clinical trial testing for pharma. The Parsortix technology uses a microfluidic technology in the form of a single use cassette to capture and then harvest CTCs from whole blood.

Sales per Business

GBP in Million2022Weight2023Weight Delta
Product
56.2 %
1 57.1 % 1 56.2 % +106.90%
Pharma Services
34.6 %
0 32.2 % 1 34.6 % +125.67%
Product Services
9.2 %
0 10.8 % 0 9.2 % +79.46%

Sales per region

GBP in Million2022Weight2023Weight Delta
Europe
33.9 %
0 44.8 % 1 33.9 % +59.01%
United Kingdom
23.1 %
0 21.2 % 1 23.1 % +128.96%
North America
23.0 %
0 34.0 % 1 23.0 % +42.09%
Rest of World
19.9 %
-- 0 19.9 % -

Managers

Managers TitleAgeSince
Founder 63 94-03-31
Director of Finance/CFO - 94-12-31
Chief Tech/Sci/R&D Officer - 23-06-04
Chief Tech/Sci/R&D Officer - 14-03-31
Chief Tech/Sci/R&D Officer - 16-10-31
Chief Tech/Sci/R&D Officer - 16-02-29
Investor Relations Contact - 20-12-31
Corporate Officer/Principal - -
Corporate Officer/Principal - 19-10-31
Corporate Officer/Principal - -

Members of the board

Members of the board TitleAgeSince
Director of Finance/CFO - 94-12-31
Founder 63 94-03-31
Director/Board Member 80 13-01-06
Chairman 65 18-10-31
Director/Board Member 57 23-01-04
Director/Board Member 56 23-01-18

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 322,641,668 294,657,644 ( 91.33 %) 0 91.33 %

Shareholders

NameEquities%Valuation
26,152,590 8.106 % 5 M p
Global Frontier Investments LLC
5.237 %
16,896,189 5.237 % 3 M p
Hargreaves Lansdown Asset Management Ltd.
3.049 %
9,835,859 3.049 % 2 M p
Baillie Gifford & Co.
2.500 %
8,064,994 2.500 % 1 M p
Chelverton Asset Management Ltd.
2.328 %
7,512,113 2.328 % 1 M p
7,316,493 2.268 % 1 M p
Global Prime Partners Ltd.
1.827 %
5,895,506 1.827 % 1 M p
Aegon Asset Management UK PLC
1.642 %
5,296,443 1.642 % 937 312 p
IG Markets Ltd.
1.060 %
3,419,514 1.060 % 605 151 p
Evelyn Partners Investment Management LLP
1.010 %
3,257,252 1.010 % 576 436 p

Company contact information

ANGLE Plc

The Surrey Research Park 10 Nugent Road

GU2 7AF, Guildford

+44 14 8334 3434

http://www.angleplc.com
address ANGLE plc(AGL)